Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients With Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome

NCT02073565 is registered in ClinicalTrials.gov with OrbusNeich as lead sponsor.

NCT NCT02073565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02073565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients With Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome
Lead sponsor
OrbusNeich
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
December 31, 2021
Enrollment
572 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis, non st segment elevation acute coronary syndrome